Search

Displaying results 1071 - 1080 of 10000 in total
  1. Drug

    Drotrecogin alfa

    go.drugbank.com/drugs/DB00055
    ApprovedWithdrawn

    It is a glycoprotein of approximately 55 kilodalton molecular weight, consisting of a heavy chain and a light chain linked by a disulfide bond. … Drotrecogin alfa is activated human protein C that is synthesized by recombinant DNA technology.

    Categories: Enzymes and Coenzymes, Blood and Blood Forming OrgansProducts: Xigris (20mg/vial), Xigris (5mg/vial)
  2. Drug

    Furazolidone

    go.drugbank.com/drugs/DB00614
    InvestigationalVet approved

    A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone binds bacterial DNA which leads to the gradual inhibition of monoamine oxidase.

    Categories: metronidazole and furazolidone, Genito Urinary System and Sex HormonesSynonyms: N-(5-Nitro-2-furfurylidene)-3-amino-2-oxazolidone, 5-Nitro-N-(2-oxo-3-oxazolidinyl)-2-furanmethanimine
  3. Drug

    Botrytis cinerea

    go.drugbank.com/drugs/DB10428
    Approved

    Botrytis cinerea is a fungus which can provoke allergic reactions. Botrytis cinerea extract is used in allergenic testing.

    Categories: Non-Standardized Fungal Allergenic ExtractProducts: Molds, Rusts and Smuts, Botrytis cinerea
  4. Drug

    Mus musculus skin

    go.drugbank.com/drugs/DB10412
    Approved

    Mus musculus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic ExtractProducts: Mouse Hair and Epithelia
  5. Drug

    Flurazepam

    go.drugbank.com/drugs/DB00690
    ApprovedIllicit

    A benzodiazepine derivative used mainly as a hypnotic.

    Categories: Hypnotics and Sedatives, Benzodiazepines and benzodiazepine derivativesProducts: Somnol 15mg, Novo-flupam Cap 15mg
  6. Drug

    Siponimod

    go.drugbank.com/drugs/DB12371
    ApprovedInvestigational

    It was approved by the FDA on March 26, 2019 [L5792] and by Health Canada on February 20, 2020. … Symptoms may include but are not limited to fatigue, gait changes, bowel or bladder dysfunction, abnormal muscle twitching, vision disturbance, and depressing or mood swings.

    Categories: Antineoplastic and Immunomodulating AgentsProducts: MAYZENT FILM-COATED TABLET 2MG
  7. Drug

    Eletriptan

    go.drugbank.com/drugs/DB00216
    ApprovedInvestigational

    Eletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches.

    Categories: Serotonin-1b and Serotonin-1d Receptor Agonist, Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: RELPAX 20MG, ELETRIP HORMOSAN 20MG
  8. Drug

    Saxagliptin

    go.drugbank.com/drugs/DB06335
    ApprovedInvestigational

    Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.

    Mixtures: Saxagliptin and Metformin, Saxagliptin and MetforminCategories: Alimentary Tract and Metabolism, metformin and saxagliptin
  9. Drug

    Doxapram

    go.drugbank.com/drugs/DB00561
    ApprovedInvestigationalVet approved

    A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)

    Products: Dopram Inj 20mg/ml, Dopram Injectable Liq 20mg/ml
  10. Drug

    Ethionamide

    go.drugbank.com/drugs/DB00609
    ApprovedInvestigationalWithdrawn

    (From Smith and Reynard, Textbook of Pharmacology, 1992, p868)

    Products: Ethomid Tablets 250mg, ETIONAMIDA TABLETAS 250MG